The expression of WDR5 was shown to decrease in a concentration-dependent and time-dependent manner post HD treatment, while the expressions of other proteins (ASH2L and RBBP5) were not affected (Fig. 6b, c). The gene discussed is RBBP5; the disease is Huntington disease.